Miguel Ángel
Hernández Pérez
Profesor Asociado Asistencial
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Icahn School of Medicine at Mount Sinai (1)
2018
-
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
The Lancet Neurology, Vol. 17, Núm. 5, pp. 405-415